Rot A, Krieger M, Brunner T, Bischoff S C, Schall T J, Dahinden C A
Institute of Clinical Immunology, Bern, Switzerland.
J Exp Med. 1992 Dec 1;176(6):1489-95. doi: 10.1084/jem.176.6.1489.
The cellular infiltrates of certain inflammatory processes found in parasitic infection or in allergic diseases consist predominantly of eosinophilic granulocytes, often in association with activated T cells. This suggests the existence of chemotactic agonists specific for eosinophils and lymphocyte subsets devoid of neutrophil-activating properties. We therefore examined four members of the intercrine/chemokine superfamily of cytokines (monocyte chemotactic peptide 1 [MCP-1], RANTES, macrophage inflammatory protein 1 alpha [MIP-1 alpha], and MIP-1 beta), which do not activate neutrophils, for their ability to affect different eosinophil effector functions. RANTES strongly attracted normal human eosinophils by a chemotactic rather than a chemokinetic mechanism with a similar efficacy as the most potent chemotactic myeloid cell agonist, C5a. MIP-1 alpha also induced eosinophil migration, however, with lower efficacy. RANTES and MIP-1 alpha induced eosinophil cationic protein release in cytochalasin B-treated eosinophils, but did not promote leukotriene C4 formation by eosinophils, even after preincubation with interleukin 3 (IL-3), in contrast to other chemotactic agonists such as C5a and formyl-methionyl-leucyl-phenylalanine (FMLP). RANTES, but not MIP-1 alpha, induced a biphasic chemiluminescence response, however, of lower magnitude than C5a. RANTES and MIP-1 alpha both promoted identical transient changes in intracellular free calcium concentration ([Ca2+]i), with kinetics similar to those induced by chemotactic peptides known to interact with G protein-coupled receptors. No cross-desensitization towards other peptide agonists (e.g., C5a, IL-8, FMLP) was observed, suggesting the presence of specific receptors. Despite its weaker eosinophil-activating properties, MIP-1 alpha was at least 10 times more potent on a molar basis than RANTES at inducing [Ca2+]i changes. Interestingly, RANTES deactivated the MIP-1 alpha-induced [Ca2+]i changes, while the RANTES response was preserved after MIP-1 alpha stimulation. MCP-1, a potent monocyte chemoattractant and basophil agonist, as well as MIP-1 beta, a peptide with pronounced homology to MIP-1 alpha, did not activate the eosinophil functions tested. Our results indicate that RANTES and MIP-1 alpha are crucial mediators of inflammatory processes in which eosinophils predominate.
在寄生虫感染或过敏性疾病中发现的某些炎症过程的细胞浸润主要由嗜酸性粒细胞组成,通常与活化的T细胞有关。这表明存在对嗜酸性粒细胞和缺乏中性粒细胞激活特性的淋巴细胞亚群具有特异性的趋化激动剂。因此,我们研究了细胞因子的内分泌/趋化因子超家族的四个成员(单核细胞趋化肽1 [MCP-1]、RANTES、巨噬细胞炎性蛋白1α [MIP-1α]和MIP-1β),它们不激活中性粒细胞,以研究它们影响不同嗜酸性粒细胞效应功能的能力。RANTES通过趋化而非趋化动力学机制强烈吸引正常人嗜酸性粒细胞,其效力与最有效的趋化髓样细胞激动剂C5a相似。MIP-1α也诱导嗜酸性粒细胞迁移,然而,效力较低。RANTES和MIP-1α在细胞松弛素B处理的嗜酸性粒细胞中诱导嗜酸性粒细胞阳离子蛋白释放,但与其他趋化激动剂如C5a和甲酰甲硫氨酰亮氨酰苯丙氨酸(FMLP)不同,即使在与白细胞介素3(IL-3)预孵育后,它们也不促进嗜酸性粒细胞形成白三烯C4。RANTES而非MIP-1α诱导双相化学发光反应,然而,其强度低于C5a。RANTES和MIP-1α都促进细胞内游离钙浓度([Ca2+]i)的相同瞬时变化,其动力学与已知与G蛋白偶联受体相互作用的趋化肽诱导的动力学相似。未观察到对其他肽激动剂(如C5a、IL-8、FMLP)的交叉脱敏,表明存在特异性受体。尽管MIP-1α的嗜酸性粒细胞激活特性较弱,但在诱导[Ca2+]i变化方面,其摩尔效力至少比RANTES强10倍。有趣的是,RANTES使MIP-1α诱导的[Ca2+]i变化失活,而在MIP-1α刺激后RANTES反应得以保留。MCP-1是一种有效的单核细胞趋化剂和嗜碱性粒细胞激动剂,以及与MIP-1α具有明显同源性的肽MIP-1β,均未激活所测试酌嗜酸性粒细胞功能。我们的结果表明,RANTES和MIP-1α是嗜酸性粒细胞占主导的炎症过程的关键介质。